ONS/ASCO Guideline on the Management of Antineoplastic Extravasation
Clinical Journal of Oncology Nursing · 2025
DOI: 10.1188/25.cjon.384-399 ↗Kurz gefasst
Leitlinie in der Zeitschrift Clinical Journal of Oncology Nursing, 2025. Verfasst von Tanya Thomas und 16 weiteren Autor:innen. Beteiligte Einrichtung: Tanya Thomas. Hauptthemen laut MEDLINE: Extravasation of Diagnostic and Therapeutic Materials, Antineoplastic Agents, Oncology Nursing, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tanya Thomas.
- Caroline Clark.
- Chelsea Backler.
- Kari Bohlke.
- Deena Centofanti.
- Aparna C. Jotwani.
Zitieren
APA
Thomas, T., Clark, C., Backler, C., Bohlke, K., Centofanti, D., Jotwani, A. C., Cope, D. G., Dalton, K. A., Gochett, C. G., Henney, V., King, G., Moore, D. C., Dzimitrowicz McManus, H., Anderson, H. M., Moriarty, K. A., DiValerio Gibbs, K., & Morgan, R. L. (2025). ONS/ASCO Guideline on the Management of Antineoplastic Extravasation. Clinical Journal of Oncology Nursing. https://doi.org/10.1188/25.cjon.384-399
Vancouver
Thomas T, Clark C, Backler C, Bohlke K, Centofanti D, Jotwani AC, et al. ONS/ASCO Guideline on the Management of Antineoplastic Extravasation. Clinical Journal of Oncology Nursing. 2025. doi:10.1188/25.cjon.384-399
BibTeX
@article{Thomas2025,
author = {Thomas, Tanya and Clark, Caroline and Backler, Chelsea and Bohlke, Kari and Centofanti, Deena and Jotwani, Aparna C and Cope, Diane G and Dalton, Kerri A and Gochett, Celestine G and Henney, Victoria and King, Gwen and Moore, Donald C and Dzimitrowicz McManus, Hannah and Anderson, Holly M and Moriarty, Kerri A and DiValerio Gibbs, Karen and Morgan, Rebecca L},
title = {ONS/ASCO Guideline on the Management of Antineoplastic Extravasation},
journal = {Clinical Journal of Oncology Nursing},
year = {2025},
doi = {10.1188/25.cjon.384-399}
}
EUVIMED